(Q48445338)

11 February 2018

title

Lifestyle behaviours and components of energy balance as independent predictors of ghrelin and adiponectin in young non-obese women (English)

1 reference

11 February 2018

0 references

8

Cianflone K

1 reference

11 February 2018

author name string

St-Pierre DH

1

1 reference

11 February 2018

Faraj M

2

1 reference

11 February 2018

Karelis AD

3

1 reference

11 February 2018

Conus F

4

1 reference

11 February 2018

Henry JF

5

1 reference

11 February 2018

St-Onge M

6

1 reference

11 February 2018

Tremblay-Lebeau A

7

1 reference

11 February 2018

Rabasa-Lhoret R

9

1 reference

11 February 2018

publication date

1 April 2006

1 reference

11 February 2018

published in

Diabetes and Metabolism

1 reference

11 February 2018

volume

32

1 reference

11 February 2018

issue

2

1 reference

11 February 2018

page(s)

131-139

1 reference

11 February 2018

Ghrelin is a growth-hormone-releasing acylated peptide from stomach

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Ghrelin induces adiposity in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Ghrelin enhances appetite and increases food intake in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Ghrelin causes hyperphagia and obesity in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Circulating ghrelin levels are decreased in human obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

The role of neuropeptide Y in the antiobesity action of the obese gene product

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Central administration of leptin inhibits food intake and activates the sympathetic nervous system in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Effects of recombinant leptin therapy in a child with congenital leptin deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Diabetes, lipids, and adipocyte secretagogues

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Leptin and soluble leptin receptor levels in obese and weight-losing individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Leptin and hyperleptinemia - from friend to foe for cardiovascular function

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Adiponectin: systemic contributor to insulin sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Plasma adiponectin levels and risk of myocardial infarction in men.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Adipocytokines, body composition, and fitness in children

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Physical activity assessment with accelerometers

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Validity, reliability, and calibration of the Tritrac accelerometer as a measure of physical activity

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Relationship between ghrelin and energy expenditure in healthy young women

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Elevated plasma ghrelin levels in Prader–Willi syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Physical activity and resting metabolic rate.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Human plasma ghrelin levels increase during a one-year exercise program

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Weight loss increases circulating levels of ghrelin in human obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Ghrelin can bind to a species of high density lipoprotein associated with paraoxonase

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Effects of weight loss in overweight/obese individuals and long-term lipid outcomes--a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Weight-reducing effects of the plasma protein encoded by the obese gene

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Acute stimulation of glucose metabolism in mice by leptin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Leptin inhibits insulin-stimulated incorporation of glucose into lipids and stimulates glucose decarboxylation in isolated rat adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Leptin: the tale of an obesity gene

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Adiponectin and development of type 2 diabetes in the Pima Indian population

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

Low adiponectin levels predict type 2 diabetes in Mexican children.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

In-person vs telephone-administered multiple-pass 24-hour recalls in women: validation with doubly labeled water.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

A comparison of the validity of three scales for the assessment of dietary restraint

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970259-8

7 January 2021

10.1016/S1262-3636(07)70259-8

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018